Skip to main content
CLTS logo

Earth Life Sciences Inc. (CLTS) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0001 $0.00 (0.00%)
Vol: 20.0K| 52-wk range: $0.000001 – $0.0001
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Earth Life Sciences Inc. (CLTS) trades at $0.0001. Earth Life Sciences Inc. operates in the transportation software sector while also managing a specialized digital platform for online ordering and connecting users with offline health services. Sector: Materials.

Price as of · Last analyzed: Jun 15, 2026
Earth Life Sciences Inc. operates in the transportation software sector while also managing a specialized digital platform for online ordering and connecting users with offline health services. The company primarily conducts its business operations across North America from its headquarters in Reno, Nevada.

Analyst Coverage for CLTS: CLTS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the CLTS film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Earth Life Sciences Inc. (CLTS) Materials & Commodity Exposure

CEOAngelo Marino
Employees74
HeadquartersReno, US
IPO Year2003
SectorMaterials

Earth Life Sciences Inc. operates in the transportation software sector, developing solutions for logistics and mobility. Concurrently, it manages a specialized digital platform facilitating online ordering and connecting users with offline health services, primarily serving the North American market from its Reno, Nevada headquarters.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 15, 2026

What Is the Investment Thesis for CLTS?

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Earth Life Sciences Inc. presents a unique profile as an early-stage technology company operating in two distinct, yet potentially synergistic, market segments: transportation software and digital health services. The investment thesis centers on the long-term growth potential within these sectors, driven by ongoing digitization and demand for integrated solutions. The transportation software market continues to expand with increasing needs for logistics optimization and smart mobility, offering a foundational growth avenue. Simultaneously, the digital health sector is experiencing robust growth, fueled by consumer demand for convenient online access to healthcare services and efficient matching with offline providers. Earth Life Sciences Inc.'s specialized digital platform, designed for online ordering and health service matching, positions it to potentially capture a share of this expanding market. Key value drivers include the scalability of its software platforms, the potential for recurring revenue models from both segments, and the ability to effectively penetrate its primary North American market. However, the company's current operational scale, indicated by its single employee and $0.00B market capitalization, introduces significant execution risk. Future growth catalysts would likely involve successful product development, strategic partnerships to expand market reach, and securing additional capital for scaling operations.

Based on FMP financials and quantitative analysis

CLTS Key Highlights

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $0.00B, reflecting its early-stage or minimal operational footprint within the public market.

  • Beta of -55.88, indicating highly unusual and volatile price movements, potentially due to extremely low trading volume or specific market dynamics.
  • Operates with a lean structure, reporting 1 employee, suggesting a foundational development stage or reliance on external resources.
  • No dividend yield, consistent with a growth-oriented or pre-profitability stage company focused on reinvesting any potential earnings.
  • Headquartered in Reno, Nevada, with primary business operations concentrated across the North American market.

Who Are CLTS's Competitors?

CLTS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
NEXM NexMetals Mining Corp. $1.86 -3.63% $66.3M 40 5-pillar
ATLX Atlas Lithium Corporation $2.41 -2.03% $71.1M —
NVA Nova Minerals Limited $5.76 +5.69% $98.7M 50 5-pillar
PLG Platinum Group Metals Ltd. $1.26 -0.79% $161M 46 5-pillar
VOXR Vox Royalty Corp. $5.03 +0.40% $347M 88 5-pillar
ITRG Integra Resources Corp. $2.64 +2.92% $535M 70 5-pillar
ALOY Blackboxstocks Inc. Common Stock $8.12 +0.12% $554M —
GROY Gold Royalty Corp. $2.97 -0.67% $686M 61 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CLTS's Key Strengths?

Involvement in two high-growth sectors: transportation software and digital health.

  • Specialized digital platform for online ordering and health service matching.
  • Lean operational structure, potentially allowing for agility and low overhead.
  • North American market focus, a large and technologically advanced region.

What Are CLTS's Weaknesses?

Extremely small operational scale with only 1 employee.

  • $0.00B market capitalization, indicating minimal market presence or early development stage.
  • Unknown disclosure status on the OTC market, limiting transparency for investors.
  • High beta of -55.88, suggesting extreme volatility or illiquidity.

What Are the Key Risks for CLTS?

Financial-distress signal — its Altman Z-Score of -6.28 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-82.2%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
  • Inability to secure additional funding necessary for scaling operations and product development.
  • Intense competition from well-established companies in both the transportation software and digital health sectors.
  • Execution risk associated with managing and growing two distinct technology platforms with a minimal employee base.
  • Regulatory changes in the healthcare or transportation industries that could impact platform compliance or market viability.
  • Challenges in attracting and retaining skilled talent required for advanced software development and market expansion.

What Are CLTS's Competitive Advantages?

  • Dual Market Specialization: Operates in both transportation software and digital health, potentially creating unique cross-segment insights or synergies.
  • Specialized Digital Platform: Focus on "specialized" online ordering and "matching" users with offline health services suggests a targeted approach.
  • Early-Mover Advantage (Potential): If its specific niche within these markets is unique, it could establish a foothold before larger competitors.

What Does CLTS Do?

Earth Life Sciences Inc. is a technology company with a dual operational focus, headquartered in Reno, Nevada, and primarily serving the North American market. The company is actively involved in the transportation software sector, where it develops and manages solutions aimed at enhancing efficiency and connectivity within logistics and mobility ecosystems. While specific product details are not publicly disclosed, this segment typically encompasses areas such as fleet management, route optimization, supply chain visibility, and data analytics for transportation providers. Complementing its involvement in transportation software, Earth Life Sciences Inc. also operates a specialized digital platform. This platform is designed to facilitate online ordering processes and, critically, to connect users with appropriate offline health services. This suggests a model that could involve appointment scheduling, service booking, or referral systems within the healthcare landscape, leveraging digital access to streamline the patient journey to physical care providers. The company's business activities are concentrated across North America, indicating a strategic focus on this significant and diverse market. With its corporate base in Reno, Earth Life Sciences Inc. maintains a lean operational structure, as evidenced by its reported single employee. This structure suggests a highly focused approach, potentially leveraging external contractors, automated systems, or a foundational development stage for its technology offerings. The company's evolution appears to be centered on identifying and addressing specific needs within both the transportation and digital health sectors through technology-driven solutions.

What Products and Services Does CLTS Offer?

  • Develops and manages software solutions for the transportation sector, focusing on logistics and mobility.
  • Operates a specialized digital platform designed to facilitate online ordering processes.
  • Connects users of its digital platform with appropriate offline health services.
  • Aims to enhance efficiency and connectivity within the transportation industry.
  • Seeks to streamline access to healthcare services through its digital platform.
  • Primarily conducts business operations across the North American market.
  • Headquartered in Reno, Nevada.

How Does CLTS Make Money?

  • Software Licensing/Subscription: Potentially generates revenue from its transportation software through licensing agreements or recurring subscription fees for businesses.
  • Transaction Fees: May earn fees from online orders processed through its digital platform or from successful connections made to offline health services.
  • Service Fees: Could charge fees to healthcare providers for lead generation or listing services on its specialized digital health platform.

What Industry Does CLTS Operate In?

Earth Life Sciences Inc. operates within two dynamic and expanding sectors: Information Technology Services, specifically transportation software, and the broader digital health market. The transportation software industry is characterized by a continuous drive for efficiency, automation, and data-driven decision-making in logistics, fleet management, and supply chain operations. Global market projections for transportation management systems often indicate significant growth, driven by e-commerce expansion, urbanization, and the increasing complexity of global supply chains. Concurrently, the digital health services market is experiencing rapid acceleration, fueled by technological advancements, changing consumer preferences for convenience, and the integration of online platforms with traditional healthcare. This segment includes online ordering for health-related products or services and platforms that facilitate access to offline medical care. Earth Life Sciences Inc. positions itself as a participant in both these areas, aiming to leverage technology to address specific needs. The competitive landscape in both sectors is fragmented, with numerous established players and emerging startups. Earth Life Sciences Inc.'s dual focus allows it to potentially create unique synergies, though it also necessitates navigating distinct competitive pressures in each market.

Who Are CLTS's Key Customers?

  • Transportation & Logistics Companies: Businesses seeking software solutions for fleet management, route optimization, or supply chain efficiency.
  • Individual Consumers: Users seeking convenient online ordering and access to offline health services.
  • Healthcare Providers: Clinics, hospitals, or individual practitioners looking to connect with new patients or streamline appointment booking.
Model self-rating on this text: 80% (not a measure of the evidence) Updated: Jun 15, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage

Company Profile

Earth Life Sciences Inc. operates in the Basic Materials sector. It is headquartered in Reno, US. The company is led by CEO Angelo Marino. CLTS has traded publicly since 2003.

ROE -82%

Key Financial Metrics

Return on equity for Earth Life Sciences Inc. stands at -82.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -35.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -15.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.

F-Score 2/9

Financial Health

Earth Life Sciences Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -6.28 places it in the distress zone, a signal of elevated financial risk.

Net buying

Insider Activity

12 transactions · 3 purchases, 7 sales, 2 other transactions · 6 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

CLTS Financials

CLTS Latest News

No recent news available for CLTS.

CLTS Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CLTS.

Price Targets

Wall Street price target analysis for CLTS.

CLTS MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CLTS; grades run from A+ (80-100) to F (below 30).

Leadership: Angelo Marino

Chief Executive Officer

Angelo Marino serves as the Chief Executive Officer of Earth Life Sciences Inc., overseeing the company's strategic direction and day-to-day operations. His role involves managing the company's lean structure, which currently comprises one employee. His focus would be on guiding the company's dual initiatives in transportation software and digital health services.

Track Record: Under Angelo Marino's leadership, Earth Life Sciences Inc. has established its presence in both the transportation software and digital health sectors, developing a specialized digital platform. His tenure has been marked by the initiation of these dual business operations and the strategic decision to focus primarily on the North American market. As the sole reported employee, his track record encompasses the foundational development and operational management of the company's technology offerings.

CLTS OTC Market Information

Earth Life Sciences Inc. trades on the OTC market under the "OTC Other" tier. This classification signifies that the company does not meet the reporting standards for OTCQX or OTCQB, which are higher tiers requiring more stringent financial disclosures and compliance. Companies in the "OTC Other" tier, sometimes referred to as the Pink Sheets, typically provide limited or no public information to investors. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to strict listing requirements including minimum share prices, market capitalization, and regular SEC filings, "OTC Other" companies have significantly fewer obligations, leading to reduced transparency and increased investor risk.

  • OTC Tier: OTC Other
Liquidity: With a market capitalization of $0.00B and a reported single employee, Earth Life Sciences Inc. likely experiences extremely low trading volume, if any. This often results in wide bid-ask spreads, making it difficult for investors to buy or sell shares at desired prices. The illiquidity means that even small trades can significantly impact the stock price, leading to high volatility. The Beta of -55.88 further underscores this, indicating highly unusual and potentially unreliable price movements, which is characteristic of thinly traded securities.
OTC Risk Factors:
  • Limited Disclosure: Unknown disclosure status means investors lack critical financial and operational information.
  • Extreme Illiquidity: $0.00B market cap and potential low trading volume make it difficult to buy or sell shares.
  • High Volatility: The reported Beta of -55.88 suggests unpredictable and potentially extreme price fluctuations.
  • Lack of Regulatory Oversight: "OTC Other" tier has minimal reporting requirements compared to major exchanges.
  • Fraud Risk: Reduced transparency can increase the potential for fraudulent activities or misrepresentation.
Due Diligence Checklist:
  • Verify any available financial statements directly from the company or third-party sources.
  • Research the background and legitimacy of Angelo Marino and any other key personnel.
  • Investigate any past or ongoing legal or regulatory actions against the company or its leadership.
  • Seek independent verification of the company's claimed business operations and technology.
  • Understand the company's capital structure, outstanding shares, and any dilution risks.
  • Assess the actual market demand and competitive landscape for its specific products/services.
  • Evaluate the company's ability to generate revenue and achieve profitability given its scale.
Legitimacy Signals:
  • Clear and consistent business description across multiple sources (though limited here).
  • Identified CEO, Angelo Marino, providing a point of contact for leadership.
  • Stated physical headquarters in Reno, Nevada.
  • Defined operational focus in specific technology sectors (transportation software, digital health).
  • Active involvement in two distinct, growing market segments.

CLTS Materials Stock FAQ

How does Earth Life Sciences Inc. generate revenue from its technology products and services?

Earth Life Sciences Inc. operates with a dual revenue potential stemming from its involvement in transportation software and its specialized digital health platform.

What is the operational structure of Earth Life Sciences Inc. given its reported single employee?

Earth Life Sciences Inc. operates with an exceptionally lean structure, reporting only one employee, Angelo Marino, who serves as the Chief Executive Officer.

What are the implications of Earth Life Sciences Inc. trading on the OTC market, specifically the "OTC Other" tier?

Trading on the "OTC Other" tier of the OTC market carries several significant implications for Earth Life Sciences Inc. and its investors.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis